M. Bouillon-Pichault

Translational Model‐Based Strategy to Guide the Choice of Clinical Doses for Antibody–Drug Conjugates

C. Nicolazzi, C. Veyrat‐Follet, M. Bouillon-Pichault, 2017, Journal of clinical pharmacology.

Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment.

O. Launay, S. Chhun, V. Jullien, 2009, The Journal of antimicrobial chemotherapy.

Pharmacokinetic design optimization in children and estimation of maturation parameters: example of cytochrome P450 3A4

V. Jullien, M. Tod, G. Pons, 2011, Journal of Pharmacokinetics and Pharmacodynamics.

Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysis.

C. Delaugerre, S. Urien, S. Blanche, 2007, British journal of clinical pharmacology.

Topiramate pharmacokinetics in infants and young children: Contribution of population analysis

O. Dulac, C. Chiron, R. Nabbout, 2011, Epilepsy Research.

A population analysis of weight-related differences in lopinavir pharmacokinetics and possible consequences for protease inhibitor-naive and -experienced patients

N. Dupin, O. Lortholary, O. Launay, 2009, Antiviral therapy.

Pharmacokinetic design optimization in children and estimation of maturation parameters: example of cytochrome P450 3A4

V. Jullien, M. Tod, G. Pons, 2010, Journal of Pharmacokinetics and Pharmacodynamics.